Pharma Peak Research Emerges, Set to Accelerate Biopharmaceutical Development in the Philippines

Makati, Philippines - May 11, 2022 - Pharma Peak Research (PPR), a Philippine-based Contract Research Organization (CRO), today announced its official launch. The company is poised to revolutionize biotech and biopharmaceutical development by providing end-to-end services and product development strategies for emerging biotech and pharmaceutical companies that do not have a local operating entity in the Philippines.

PPR's core mission is to accelerate access to the rapidly growing pharmaceutical and biotechnology markets by guiding sponsors through strategic and regulatory alignment with Philippine authorities. As a full-service CRO, Pharma Peak Research offers a comprehensive suite of services, ranging from clinical trial management and regulatory support to product strategy consultation and data analysis, all tailored to ensure efficient, high-quality clinical studies.

"We are thrilled to unveil Pharma Peak Research and serve as a bridge between global biotech innovations and the Philippine market," said a spokesperson for Pharma Peak Research Philippines Inc. "Our mission is to provide pharmaceutical companies with the knowledge, and support they need to navigate the complexities of product development and registration in the country."

By leveraging extensive local expertise and global best practices, PPR enables sponsors to rapidly generate robust clinical data that can expedite new biopharmaceutical product registration. This agile approach helps clients enhance product value, gain faster market access, and ultimately make life-changing therapies available to patients sooner.